Cargando…

Relationship Between Serum Norepinephrine Levels at ICU Admission and the Risk of ICU-Acquired Delirium: Secondary Analysis of the Melatonin Evaluation of Lowered Inflammation of ICU Trial

Abnormal secretion of catecholamines is well known to cause delirium. In particular, disturbances of catecholamine balance can cause ICU-acquired delirium. The aim of this study was to evaluate the association between the serum levels of catecholamines and the risk of occurrence of ICU-acquired deli...

Descripción completa

Detalles Bibliográficos
Autores principales: Yasuda, Yuma, Nishikimi, Mitsuaki, Nishida, Kazuki, Takahashi, Kunihiko, Numaguchi, Atsushi, Higashi, Michiko, Matsui, Shigeyuki, Matsuda, Naoyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069595/
https://www.ncbi.nlm.nih.gov/pubmed/32211614
http://dx.doi.org/10.1097/CCE.0000000000000082
_version_ 1783505808659578880
author Yasuda, Yuma
Nishikimi, Mitsuaki
Nishida, Kazuki
Takahashi, Kunihiko
Numaguchi, Atsushi
Higashi, Michiko
Matsui, Shigeyuki
Matsuda, Naoyuki
author_facet Yasuda, Yuma
Nishikimi, Mitsuaki
Nishida, Kazuki
Takahashi, Kunihiko
Numaguchi, Atsushi
Higashi, Michiko
Matsui, Shigeyuki
Matsuda, Naoyuki
author_sort Yasuda, Yuma
collection PubMed
description Abnormal secretion of catecholamines is well known to cause delirium. In particular, disturbances of catecholamine balance can cause ICU-acquired delirium. The aim of this study was to evaluate the association between the serum levels of catecholamines and the risk of occurrence of ICU-acquired delirium separately in patients who had/had not received exogenous catecholamines before ICU admission. DESIGN: A secondary analysis of the data of 81 patients enrolled in our previous randomized clinical trial. SETTING: ICU of an academic hospital. PATIENTS: ICU patients in whom the serum levels of catecholamines were measured at ICU admission. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: We evaluated the association between the serum levels of catecholamines measured at ICU admission and the risk of ICU-acquired delirium separately in patients who had received exogenous catecholamines at ICU admission (Ex[+] group) and those who had not received exogenous catecholamines (Ex[–] group). The serum levels of norepinephrine measured at ICU admission were significantly associated with the risk of ICU-acquired delirium in the Ex(–) group (odds ratio, 2.58; 95% CI, 1.02–6.52; p = 0.046), but not in the Ex(+) group (odds ratio, 1.02; 95% CI, 0.88–1.18; p = 0.823). Furthermore, there was a statistically significant interaction effect between the serum levels of norepinephrine and the use/nonuse of exogenous catecholamines at ICU admission in relation to the risk of occurrence of ICU-acquired delirium (p(interaction) = 0.017). CONCLUSIONS: The serum levels of norepinephrine measured at admission were associated with the risk of occurrence of ICU-acquired delirium in patients who had not received exogenous catecholamines at ICU admission, whereas no such association was observed in those who had received exogenous catecholamines previously. Thus, the association between the serum levels of catecholamines measured at admission and the risk of ICU-acquired delirium differed between patients who had/had not received exogenous catecholamines at ICU admission.
format Online
Article
Text
id pubmed-7069595
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-70695952020-03-24 Relationship Between Serum Norepinephrine Levels at ICU Admission and the Risk of ICU-Acquired Delirium: Secondary Analysis of the Melatonin Evaluation of Lowered Inflammation of ICU Trial Yasuda, Yuma Nishikimi, Mitsuaki Nishida, Kazuki Takahashi, Kunihiko Numaguchi, Atsushi Higashi, Michiko Matsui, Shigeyuki Matsuda, Naoyuki Crit Care Explor Original Clinical Report Abnormal secretion of catecholamines is well known to cause delirium. In particular, disturbances of catecholamine balance can cause ICU-acquired delirium. The aim of this study was to evaluate the association between the serum levels of catecholamines and the risk of occurrence of ICU-acquired delirium separately in patients who had/had not received exogenous catecholamines before ICU admission. DESIGN: A secondary analysis of the data of 81 patients enrolled in our previous randomized clinical trial. SETTING: ICU of an academic hospital. PATIENTS: ICU patients in whom the serum levels of catecholamines were measured at ICU admission. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: We evaluated the association between the serum levels of catecholamines measured at ICU admission and the risk of ICU-acquired delirium separately in patients who had received exogenous catecholamines at ICU admission (Ex[+] group) and those who had not received exogenous catecholamines (Ex[–] group). The serum levels of norepinephrine measured at ICU admission were significantly associated with the risk of ICU-acquired delirium in the Ex(–) group (odds ratio, 2.58; 95% CI, 1.02–6.52; p = 0.046), but not in the Ex(+) group (odds ratio, 1.02; 95% CI, 0.88–1.18; p = 0.823). Furthermore, there was a statistically significant interaction effect between the serum levels of norepinephrine and the use/nonuse of exogenous catecholamines at ICU admission in relation to the risk of occurrence of ICU-acquired delirium (p(interaction) = 0.017). CONCLUSIONS: The serum levels of norepinephrine measured at admission were associated with the risk of occurrence of ICU-acquired delirium in patients who had not received exogenous catecholamines at ICU admission, whereas no such association was observed in those who had received exogenous catecholamines previously. Thus, the association between the serum levels of catecholamines measured at admission and the risk of ICU-acquired delirium differed between patients who had/had not received exogenous catecholamines at ICU admission. Wolters Kluwer Health 2020-02-24 /pmc/articles/PMC7069595/ /pubmed/32211614 http://dx.doi.org/10.1097/CCE.0000000000000082 Text en Copyright © 2020 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Original Clinical Report
Yasuda, Yuma
Nishikimi, Mitsuaki
Nishida, Kazuki
Takahashi, Kunihiko
Numaguchi, Atsushi
Higashi, Michiko
Matsui, Shigeyuki
Matsuda, Naoyuki
Relationship Between Serum Norepinephrine Levels at ICU Admission and the Risk of ICU-Acquired Delirium: Secondary Analysis of the Melatonin Evaluation of Lowered Inflammation of ICU Trial
title Relationship Between Serum Norepinephrine Levels at ICU Admission and the Risk of ICU-Acquired Delirium: Secondary Analysis of the Melatonin Evaluation of Lowered Inflammation of ICU Trial
title_full Relationship Between Serum Norepinephrine Levels at ICU Admission and the Risk of ICU-Acquired Delirium: Secondary Analysis of the Melatonin Evaluation of Lowered Inflammation of ICU Trial
title_fullStr Relationship Between Serum Norepinephrine Levels at ICU Admission and the Risk of ICU-Acquired Delirium: Secondary Analysis of the Melatonin Evaluation of Lowered Inflammation of ICU Trial
title_full_unstemmed Relationship Between Serum Norepinephrine Levels at ICU Admission and the Risk of ICU-Acquired Delirium: Secondary Analysis of the Melatonin Evaluation of Lowered Inflammation of ICU Trial
title_short Relationship Between Serum Norepinephrine Levels at ICU Admission and the Risk of ICU-Acquired Delirium: Secondary Analysis of the Melatonin Evaluation of Lowered Inflammation of ICU Trial
title_sort relationship between serum norepinephrine levels at icu admission and the risk of icu-acquired delirium: secondary analysis of the melatonin evaluation of lowered inflammation of icu trial
topic Original Clinical Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069595/
https://www.ncbi.nlm.nih.gov/pubmed/32211614
http://dx.doi.org/10.1097/CCE.0000000000000082
work_keys_str_mv AT yasudayuma relationshipbetweenserumnorepinephrinelevelsaticuadmissionandtheriskoficuacquireddeliriumsecondaryanalysisofthemelatoninevaluationofloweredinflammationoficutrial
AT nishikimimitsuaki relationshipbetweenserumnorepinephrinelevelsaticuadmissionandtheriskoficuacquireddeliriumsecondaryanalysisofthemelatoninevaluationofloweredinflammationoficutrial
AT nishidakazuki relationshipbetweenserumnorepinephrinelevelsaticuadmissionandtheriskoficuacquireddeliriumsecondaryanalysisofthemelatoninevaluationofloweredinflammationoficutrial
AT takahashikunihiko relationshipbetweenserumnorepinephrinelevelsaticuadmissionandtheriskoficuacquireddeliriumsecondaryanalysisofthemelatoninevaluationofloweredinflammationoficutrial
AT numaguchiatsushi relationshipbetweenserumnorepinephrinelevelsaticuadmissionandtheriskoficuacquireddeliriumsecondaryanalysisofthemelatoninevaluationofloweredinflammationoficutrial
AT higashimichiko relationshipbetweenserumnorepinephrinelevelsaticuadmissionandtheriskoficuacquireddeliriumsecondaryanalysisofthemelatoninevaluationofloweredinflammationoficutrial
AT matsuishigeyuki relationshipbetweenserumnorepinephrinelevelsaticuadmissionandtheriskoficuacquireddeliriumsecondaryanalysisofthemelatoninevaluationofloweredinflammationoficutrial
AT matsudanaoyuki relationshipbetweenserumnorepinephrinelevelsaticuadmissionandtheriskoficuacquireddeliriumsecondaryanalysisofthemelatoninevaluationofloweredinflammationoficutrial